126378-73-2 Usage
Description
Benzyl 3,4-dihydro-4-oxo-2-phenylpyridine-1(2H)-carboxylate is a chemical compound with potential pharmacological properties. It belongs to the class of pyridine carboxylate derivatives and is commonly used in pharmaceutical research and development due to its potential therapeutic applications. Benzyl 3,4-dihydro-4-oxo-2-phenylpyridine-1(2H)-carboxylate has shown promising bioactivity in various studies, indicating its potential for drug development. Additionally, its structural features make it an interesting target for medicinal chemistry research. Overall, benzyl 3,4-dihydro-4-oxo-2-phenylpyridine-1(2H)-carboxylate is a compound of interest in the field of drug discovery and development.
Uses
Used in Pharmaceutical Research and Development:
Benzyl 3,4-dihydro-4-oxo-2-phenylpyridine-1(2H)-carboxylate is used as a compound with potential therapeutic applications for its promising bioactivity in various studies. Its structural features make it an interesting target for medicinal chemistry research, contributing to drug discovery and development.
Used in Drug Discovery:
Benzyl 3,4-dihydro-4-oxo-2-phenylpyridine-1(2H)-carboxylate is used as a compound of interest in the field of drug discovery due to its potential pharmacological properties and its role in pharmaceutical research and development.
Check Digit Verification of cas no
The CAS Registry Mumber 126378-73-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,6,3,7 and 8 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 126378-73:
(8*1)+(7*2)+(6*6)+(5*3)+(4*7)+(3*8)+(2*7)+(1*3)=142
142 % 10 = 2
So 126378-73-2 is a valid CAS Registry Number.
126378-73-2Relevant articles and documents
THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF
-
Page/Page column 123; 124, (2017/08/01)
The invention provides a compound of formula: or a salt thereof, wherein the variables RAA, n, ring A, ring B, R1a, R1b, R2, R3, R4, R5, R6, R7, R8, and R9 have the meaning as described herein, and compositions containing such compounds and methods for using such compounds and compositions.
NK1 ANTAGONIST
-
Page/Page column 97, (2010/02/09)
The invention is to a compound exhibiting neurokinin inhibitory properties, a pharmaceutical composition comprising same and a method of treatment for neurokinin-meditated conditions.Formula (I)
Conversion of N-Acyl-2,3-dihydro-4-pyridones to 4-Chloro-1,2-dihydropyridines Using the Vilsmeier Reagent. Synthesis of (-)-Coniine and (+/-)-Lupinine
Al-awar, Rima S.,Joseph, Sajan P.,Comins, Daniel L.
, p. 7732 - 7739 (2007/10/02)
The full details are given of a study on the conversion of dihydropyridones of the type 3 to 4-chloro-1,2-dihydropyridines 4 using a Vilsmeier reagent.The use of 1 equiv of Vilsmeier reagent under mild conditions (ClCHCCl2, rt) transformed several racemic
